CAMBRIDGE, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the U.S ...

Please provide your email address to receive an email when new articles are posted on . Vericel announced FDA approval of its arthroscopically administered biologic cartilage repair product. MACI ...

CEO Nick Colangelo highlighted the company's solid start to 2025, with record first-quarter MACI revenue exceeding $46 million and total company revenue of $52.6 million. He emphasized the strong ...

STRUGGLING orthopaedic specialist Arthro Kinetics has announced it is to de-list from AIM while it continues talks with a potential buyer. But if those talks don’t complete soon, the ...